The Winter 2025 Newsletter features a note from the Director(s) regarding the launch of the UCLA Amyloid Immunotherapy Care Program, the two successful...
The Autumn 2024 Newsletter highlights Dr. Marie Kim’s answers to FAQs about donenamab and lecanemab, an overview of the 2024 Facts and Figures Report, and...
Summer 2024 Newsletter highlights UCLA faculty and researchers developing new treatments for Alzheimer’s and Parkinson’s diseases and features MD fellows...
Spring 2024 Newsletter highlights Dr. Sánchez López's answers to FAQs about lecanemab and ELHA Lab, bridging science to LA County's Latino communities.
New research presented at the Alzheimer's Association International Conference 2023 covered various aspects of Alzheimer's disease and dementia research...
As a risk factor for Alzheimer's disease (AD), the presence of the e4 version of APOE can contribute to a person's risk of developing LOAD but is in...
